Epinephrine increases malignancy of breast cancer through p38 MAPK signaling pathway in depressive disorders.
Year: 2019
Type: article
Abstract: OBJECTIVE: To uncover the possible mechanism and the effects of epinephrine on tumor growth in depression. MATERIALS AND METHODS: . RESULTS: . These two effects were significantly attenuated by propranolol (a β-adrenergic receptor antagonist). CONCLUSIONS: These findings suggest that activation of epinephrine-induced p38 MAPK signaling pathway enhances the malignancy of breast cancer in depressive disorders. More effective psychological intervention might improve prognosis of cancer patients.
Source: Europe PMC (PubMed Central)
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W3008636818
